1. P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE. (23rd June 2022) Authors: Shimoni, A.; Peczynski, C.; Labopin, M.; Angelucci, E.; Koc, Y.; Arat, M.; Tischer, J.; Sica, S.; Gülbas, Z.; Socié, G.; Blaise, D.; Pioltelli, P.; Ozdogu, H.; Vydra, J.; Ciceri, F.; Nagler, A.; Mohty, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART COALITION. (23rd June 2022) Authors: Basak, G.; Peczynski, C.; Koenecke, C.; Terwel, S.; Cabrerizo, Y.; Penack, O.; Moiseev, I.; Schoemans, H.; Fegueux, N.; Potter, V.; Zeerleder, S.; Yakoub-Agha, I.; Collin, M.; Schanz, U.; Dreger, P.; Blaise, D.; Besley, C.; Glass, B.; Mohty, M.; Chabannon, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗